The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Geriatric Medicine Market Research Report 2024
Synopsis
The global Geriatric Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Geriatric Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Geriatric Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Geriatric Medicine in Cardiovascular is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Geriatric Medicine include GSK, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Pfizer, Eli Lilly, Abbott, AstraZeneca and Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Geriatric Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Geriatric Medicine.
Report Scope
The Geriatric Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Geriatric Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Geriatric Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Boehringer Ingelheim
Novartis
Bristol-Myers Squibb
Pfizer
Eli Lilly
Abbott
AstraZeneca
Merck
Sanofi S.A.
Segment by Type
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotic
Antidepressant
Segment by Application
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Geriatric Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Geriatric Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Geriatric Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Geriatric Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Geriatric Medicine in Cardiovascular is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Geriatric Medicine include GSK, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Pfizer, Eli Lilly, Abbott, AstraZeneca and Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Geriatric Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Geriatric Medicine.
Report Scope
The Geriatric Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Geriatric Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Geriatric Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Boehringer Ingelheim
Novartis
Bristol-Myers Squibb
Pfizer
Eli Lilly
Abbott
AstraZeneca
Merck
Sanofi S.A.
Segment by Type
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotic
Antidepressant
Segment by Application
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Geriatric Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geriatric Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Analgesics
1.2.3 Antihypertensives
1.2.4 Statins
1.2.5 Antidiabetics
1.2.6 Proton Pump Inhibitor
1.2.7 Anticoagulant
1.2.8 Antipsychotic
1.2.9 Antidepressant
1.3 Market by Application
1.3.1 Global Geriatric Medicine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cardiovascular
1.3.3 Arthritis
1.3.4 Neurological
1.3.5 Cancer
1.3.6 Osteoporosis
1.3.7 Respiratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Geriatric Medicine Market Perspective (2019-2030)
2.2 Geriatric Medicine Growth Trends by Region
2.2.1 Global Geriatric Medicine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Geriatric Medicine Historic Market Size by Region (2019-2024)
2.2.3 Geriatric Medicine Forecasted Market Size by Region (2025-2030)
2.3 Geriatric Medicine Market Dynamics
2.3.1 Geriatric Medicine Industry Trends
2.3.2 Geriatric Medicine Market Drivers
2.3.3 Geriatric Medicine Market Challenges
2.3.4 Geriatric Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Geriatric Medicine Players by Revenue
3.1.1 Global Top Geriatric Medicine Players by Revenue (2019-2024)
3.1.2 Global Geriatric Medicine Revenue Market Share by Players (2019-2024)
3.2 Global Geriatric Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Geriatric Medicine Revenue
3.4 Global Geriatric Medicine Market Concentration Ratio
3.4.1 Global Geriatric Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geriatric Medicine Revenue in 2023
3.5 Geriatric Medicine Key Players Head office and Area Served
3.6 Key Players Geriatric Medicine Product Solution and Service
3.7 Date of Enter into Geriatric Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Geriatric Medicine Breakdown Data by Type
4.1 Global Geriatric Medicine Historic Market Size by Type (2019-2024)
4.2 Global Geriatric Medicine Forecasted Market Size by Type (2025-2030)
5 Geriatric Medicine Breakdown Data by Application
5.1 Global Geriatric Medicine Historic Market Size by Application (2019-2024)
5.2 Global Geriatric Medicine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Geriatric Medicine Market Size (2019-2030)
6.2 North America Geriatric Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Geriatric Medicine Market Size by Country (2019-2024)
6.4 North America Geriatric Medicine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Geriatric Medicine Market Size (2019-2030)
7.2 Europe Geriatric Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Geriatric Medicine Market Size by Country (2019-2024)
7.4 Europe Geriatric Medicine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Geriatric Medicine Market Size (2019-2030)
8.2 Asia-Pacific Geriatric Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Geriatric Medicine Market Size by Region (2019-2024)
8.4 Asia-Pacific Geriatric Medicine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Geriatric Medicine Market Size (2019-2030)
9.2 Latin America Geriatric Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Geriatric Medicine Market Size by Country (2019-2024)
9.4 Latin America Geriatric Medicine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Geriatric Medicine Market Size (2019-2030)
10.2 Middle East & Africa Geriatric Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Geriatric Medicine Market Size by Country (2019-2024)
10.4 Middle East & Africa Geriatric Medicine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Geriatric Medicine Introduction
11.1.4 GSK Revenue in Geriatric Medicine Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Geriatric Medicine Introduction
11.2.4 Boehringer Ingelheim Revenue in Geriatric Medicine Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Geriatric Medicine Introduction
11.3.4 Novartis Revenue in Geriatric Medicine Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Geriatric Medicine Introduction
11.4.4 Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Geriatric Medicine Introduction
11.5.4 Pfizer Revenue in Geriatric Medicine Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Geriatric Medicine Introduction
11.6.4 Eli Lilly Revenue in Geriatric Medicine Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Geriatric Medicine Introduction
11.7.4 Abbott Revenue in Geriatric Medicine Business (2019-2024)
11.7.5 Abbott Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Geriatric Medicine Introduction
11.8.4 AstraZeneca Revenue in Geriatric Medicine Business (2019-2024)
11.8.5 AstraZeneca Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Geriatric Medicine Introduction
11.9.4 Merck Revenue in Geriatric Medicine Business (2019-2024)
11.9.5 Merck Recent Development
11.10 Sanofi S.A.
11.10.1 Sanofi S.A. Company Detail
11.10.2 Sanofi S.A. Business Overview
11.10.3 Sanofi S.A. Geriatric Medicine Introduction
11.10.4 Sanofi S.A. Revenue in Geriatric Medicine Business (2019-2024)
11.10.5 Sanofi S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
